Oxford BioMedica Appoints Alex Lewis as Director of Corporate Activities and Strategy

24-May-2011 - United Kingdom

Oxford BioMedica announced that Dr Alex Lewis has been appointed as Director of Corporate Activities and Strategy and a member of the senior management team with immediate effect. As a result, he will step down from the Board of Oxford BioMedica.

Alex is an experienced consultant to the pharmaceutical and biotech industry with a background of over 24 years in medical research and drug development. Alex was appointed to Oxford BioMedica’s Board in April 2008 and was also Director of Transactions and Due Diligence at The Datamonitor Group until June 2009 when he became Director of Lewis Healthcare Consultants. Prior to this, he was Head of the Partnering and Due Diligence practice of Wood Mackenzie research consultants. Alex has also been involved in the provision of expert reports and technical advice for the initial public offerings and fundraising activities for biotech companies based in the US and Europe.

In place of Dr Alex Lewis, Dr Paul Blake will become Chairman of Oxford BioMedica’s remuneration committee and Dr Andrew Heath, Senior Independent Director and Deputy Chairman of Oxford BioMedica, will join the Company’s remuneration committee.

https://www.bionity.com/en/news/132626/oxford-biomedica-appoints-alex-lewis-as-director-of-corporate-activities-and-strategy.html